Current price is more than the intrinsic value
Stock has been generating better return on equity than bank FD
Stock doesn't offer attractive dividend returns
Good time to consider, as stock is not in overbought zone
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
—
—
—
Par Drugs and Chemicals provides generic drugs. The Company is engaged in the development and manufacturing of Active Pharma Ingredients (APIs) for the domestic market, as well as for exports to international markets
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Par Drugs And Chemicals Limited has informed the Exchange regarding 'Approval of Reclassification of Promoter under Regulation 31A of SEBI (ListingObligations and Disclosure Requirements) Regulations, 2015'. | Download
Par Drugs And Chemicals Limited has informed the Exchange regarding 'Approval of Reclassification of Promoter under Regulation 31A of SEBI (ListingObligations and Disclosure Requirements) Regulations, 2015'. | Download
Interim • Div/Share: ₹ 1.25
Intrinsic valueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is more than the intrinsic value